STAT

Opinion: Newborn screening saves lives. Congress needs to reauthorize the program

Newborn screening, which saves or improves the lives of thousands of babies each year, can continue to improve and thrive only if the federal-state partnership currently in place continues.
An obstetrician technician collects a blood sample from a newborn in the nursery at Community Hospital North in Indianapolis.

One of the most successful public health stories in U.S. history — the nation’s newborn screening program — was the subject of a recent reauthorization hearing held by the House Committee on Energy and Commerce.

Each year, just over 4 million babies are born in the United States. Virtually all of them have a heel pricked to draw a few drops of blood that are then analyzed to see if they have any of a . What makes this program so essential

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks